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Anderson Physicians Staff AIDS Hospital
to Advance Treatment and Halt Disease Spread
The comfort of learning that AIDS-acquired immune
deficiency syndrome-cannot be transmitted by casual contact
is chilied by the knowledge that this lethal disease may be
acquired by anyone.
"If people would realize that AIDS
is not a disease confined to a small
number of high-risk groups, we
could, through education, halt its
progress," said Peter W. A. Mansell,
M.D., UT MDAH professor of medicine and medical director of the
Institute for Immunological
Disorders.
Formerly Citizens General
Hospital, the institute opened in
Houston last September as a center Peter w. A. Mansell
for research and treatment of AIDS
and of ARC (AIDS-related complex). Owned and managed by
American Medical International (AMI}, the institute is staffed
by UT MDAH physicians, with consultants from the UT
Medical School at Houston. Partial financial support comes from
a $5 .8 million five-year contract between UT MDAH and the
National Institute of Allergy and Infectious Diseases.
Mansell's experience illustrates the now commonly heard
warning about the shared danger of AIDS. At the institute, he
said, 10% of new patients seen in the first six weeks were
heterosexuals, and nationally the proportion of heterosexual

AIDS patients is growing. The disease is spread mainly by sexual
intercourse, shared drug needles, and-although now less so
because of antibody testing-by blood transfusion.
The number of people affected by AIDS has multiplied each
year so that, by 1991, 270,000 people could have the disease if
its spread is not stopped. T wenty,five thousand of these-the
total number of AIDS patients now-would be heterosexuals.
Nearly 180,000 people would die.
In Houston, the conversion of Citizens General Hospital to
the Institute for Immunological Disorders was a response to this
dark prospect. "This place is quite literally unique," Mansell
said. ''We have the coexistence of an AIDS treatment and
evaluation unit funded by the contract. From the point of view
of faculty and clinical and basic research, it is a branch of
MDAH and the UT Medical School. We are here to provide
patients with the very best care possible, based on our experience

at Anderson in the last four and a half years, and to use this
institute as a center for research, education, and prevention."

Most Are Outpatients
Six weeks after the institute opened, at the time of this
interview, Mansell and his staff had seen more than 120 new
patients, mainly as outpatients, and they had accumulated a
month-long waiting list despite efforts to avoid it. Diagnostic
testing is faster and cheaper for outpatients, Mansell explained,
less troublesome to the patients, and provides the needed
information. "That's something we learned to do at M. D.
Anderson where we had only four beds for AIDS patients other
than those with AIDS-related cancer," he said.
No more than 15 patients have been hospitalized in the new
institute at any one time, and the average stay has been less
than eight days, compared with 20 or 30 days elsewhere, Mansell
said. The institute has a home,care unit, so discharge planning
for patients can begin almost as soon as they are admitted. Social
workers see every patient and run an active counseling program
for patients and families.
The characteristics of the disease divide the patient
population: those who have the profound immune deficiency
of AIDS that makes patients subject to potentially lethal
opportunistic infections like Pneumocystis carinii pneumonia,
autoimmune and neurologic disorders, Kaposi's sarcoma, and
lymphomas, and those who have ARC, the complex that
includes less severe systemic defects, no severe opportunistic
infections, and no Kaposi's sarcoma nor lymphoma. Patients
with ARC may or may not develop AIDS, so the clinical
treatment and counseling of the two groups is quite different.

Something Can Be Done
Although the existence of an institute devoted entirely to
AIDS research and treatment underscores the foreboding
statistics of this disease, the atmosphere of the place strongly
suggests the hope that something can and will be done about
it. Given a choice of reassignment by AMI or staying on, for
example, 70% of the Citizens General staff members kept their
posts.
continued on page 4

The Realities of Cancer in Minority Communities
by Lovell A. Jones, Ph.D.
Associate Professor of Gynecology
(Biochemistry); Director, Experimental
Gynecology Laboratory
The University of Texas M. D.
Anderson Hospital and Tumor
Institute, along with the Texas
Division of the American Cancer
Society, is sponsoring a national
symposium April 22,25, 1987, The
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Realities of Cancer in Minority
Communities. Believed to be the first such meeting of cancer
specialists from a variety of disciplines, the conference is an
opportunity to discuss a problem that has needed more attention
for a long time.
In 1984, the National Cancer Institute (NCI) set a goal of
reducing the cancer mortality rate in the United States to 50%
by the year 2000. This is an ambitious but achievable task if
current technology is applied equally to the community at large.
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Cancer is more than 100 diseases that are not randomly
distributed among the general population.
In certain small segments of the population, the cancer
mortality rate is already close to this goal. Among Seventh Day
Adventists, for example, cancer mortality is 6 1% of the general
population's; among Mormons, cancer incidence is 72% of the
general rate. Black Americans, however, have an overall cancer
incidence and mortality rate that has a disproportionately severe
impact {Figures 1 and 2).
Recent epidemiologic studies by the NCI showed that the
overall cancer survival rate for the general population rose while
the survival rate for some ethnic groups declined. The incidence,
mortality, and survival among black and Hispanic Americans,
in particular, are significantly different from those of the general
population. If the goal of a 50% cancer survival rate is to be
met by the year 2000, special programs will have to be developed
for minority communities.

Consciousness-Raising Efforts
A feasible approach to addressing the cancer needs of minority
groups is through intervention, research, and application of
cancer prevention and control principles. For these activities
to be effective in addressing the needs of U .S. minorities,
however, an effort has to be made to involve the staffs of
comprehensive cancer centers like ours, black and Hispanic
community health care professionals, and the public.
In 1985, the NCI along with several minority groups organized
events to publicize the need for minority group members to
become more aware of the cancer problem. Since black
Americans are the largest U.S. ethnic minority and the minority
population for which the most cancer data exist, the NCI
focused attention first on black populations. Several ideas were
proposed. One was to hold four regional planning sessions-in
New York, Atlanta, Chicago, and Los Angeles-to inform the
public of the NCI's intentions and to generate interest in
submitting cancer intervention grant applications. Another was
the designation of May 1985 as Black American Cancer
Awareness Month. In Texas, the legislature proclaimed this,
but throughout the state and specifically in Houston, May 1985
went by with little attention paid to the proclamation, and little
activity or awareness was reported from other metropolitan
centers.
My reaction to this lack of attention was to propose holding
a national conference sponsored by a major cancer center such
as UT MDAH. The aim was to structure a program that would
not only benefit physicians and health care professionals from
minority communities but health care professionals generally.
After senior staff members at the National Institutes of Health
reviewed it, the UT MDAH Research Council approved the
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program , and invitations went out to a group of outstanding
speakers. These will include Phillip L. Cole, M.D., University
of Alabama Comprehensive Cancer Center, Jerome Wilson,
Ph.D., Howard University Cancer Center, Mario Gonzalez,
M.D., Rio Grande Cancer Treatment Center, Carlos Vallbona,
M.D., Baylor College of Medicine, and Mary Claire King, Ph.D.,
University of California.

Data for H ispanics Are Puzzling
The cancer problem is not only a black and white problem.
The 1980 census enumerated 14.6 million Hispanic residents;
with the addit ion of undocumented Hispanic persons, the
estimate is that more than 20 million Hispanics currently live
in this country. The impoverished people in this group suffer
from lack of jobs, lack of adequate education, overcrowded
schools, indequate housing and overcrowding of urban dwellings,
lack of medical care, and chronic malnutrition. Added to this
are the relatively high smoking rates of elderly Hispanics and
trends of increasing smoking by young Hispanic males. All these
are factors known to contribute to a higher incidence, case
fatality rates, and mortality from cancer generally as well as from
neoplasms at specific sites.
One would guess, therefore, that cancer is a more severe
problem in the Hispanic than in the white population. Yet data
on five,year survival rates from the Surveillance, Epidemiology
and End Results (SEER) Program (San Francisco/Oakland and
New Mexico) show that, except for the rates for bladder cancer
and Hodgkin's disease, the rates are similar among the Hispanic
and white non ,Hispanic populations. H ispanic women have a
slightly h igher survival rate from cancer of the ovary than do
white non,Hispanic persons, whereas Mexican,American
women with breast cancer are reported to have a prognosis worse
than that of women in the general population.
Why these apparent paradoxes and this recital of isolated facts?
One clue to this contradictory information is that virtually no
national mortality data exist on Hispanics in the U.S., and there
is no source of data on cancer incidence that represents the
whole Hispanic population in the U .S.
0
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Figure 1. Age-adjusted cancer incidence (per 100,000) by racial/ethnic
group: 19 78-1981 -all sites combined. (From Cancer Among Blacks
and Other Minorities: Statistical Profiles, National Cancer Institute,
1986.)

Information Base Is Not Reliable
Although the information concerning black Americans is not
as limited as that for Hispanics, the data on cancer incidence
provided by the SEER Program come from 11 locally based
cancer registries that cover only a small percentage of the
minority population. Minority groups have expressed concern
recently about the SEER Program's limited data collection
because the SEER data, despite inadequacies, are perceived as
authoritative by policy makers and health care professionals.

Japanese

51

Anglo

50
47

Hispanic
Filipino

45

Chinese

44
44

Hawaiian
Black
Native American

3B

34

Figure 2. Five-year relative survival rates (percentages) by racial/ethnic
group: 1973-1981-all sites combined. (From Cancer Among Blacks
and Other Minorities: Statistical Profiles, National Cancer Institute,
1986.)

In addition to the overall lower survival rate from cancer, the
data on black Americans show that their survival rates for
certain types of cancer continue to be significantly lower than
those of white Americans. The five,year survival rate of 63%
for black women with breast cancer, for instance, is significantly
lower than the 75% rate for white women with the same disease.
Although the majority of white and black women discover their
tumors, the tumors in black women are larger, more often
involve nodes, and are more extensive by the time they are
diagnosed. Black women delay longer in seeking treatment.

Barriers to Health Care
Failure to reduce the incidence and mortality rate of cancer
in the minority communities can be ascribed to the barriers
between these communities and health care, barriers that are
both structural and institutional and are kept in place by
problems of money, access, and availability. Behavioral and
cultural barriers also exist, maintained by outdated knowledge,
attitudes, and practices.
Many of these barriers are deeply set in socioeconomic
circumstances and require creative methods to circumvent and
overcome. One way of beginning to solve the problem is to bring
together professionals from major cancer centers, minority
researchers and physicians, primary care community physicians,
persons in the minority community involved in health care,
continued on page 8
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AIDS Hospital
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continued from page l

One reason for hope, Mansell explained, is that the disease
lost some of its mystery when, in 1983, French scientists
identified the virus, now called human immunodeficiency virus
(HIV)-and formerly human T,cell lymphotropic virus type
III/lymphadenopathy,associated virus (HTLV,III/LAV)-as a
necessary factor in the disease, though not its total cause.
It's easy now to do the antibody test, Mansell said. Culturing
the virus, which is not easy, is being done by F. Blaine Hollinger,
M.D., a virologist at Baylor College of Medicine.

A vaccination trial, the first, is to begin early this year at the
institute with a synthetic peptide structured like some of the
HIV virus proteins. "Theoretically, if an individual produces
an antibody against the peptide, he should produce an antibody
against the virus. This happens in laboratory mammals,''
Mansell said. "There are obviously a lot of unanswered
questions-whom to vaccinate, the end points to look for, the
duration of the trial, and others- but somebody's got to start."
The vaccine will be given to from 30 to 50 people who have
never come in contact with the virus. Mansell's team is inclined
to offer it to homosexual men because they are at highest risk
and can be tested conclusively.

Lessons for Cancer Research
Drug Trials and Vaccination
''We have a peculiar opportunity here in the sense that we
have a physical plant, and we have the largest continually
followed up group of patients with AIDS,related problems in
the world," Mansell said. "We will be testing new drugs as we've
done at Anderson since January 1982. The large number of
biological response modifiers we tested were unsuccessful for the
simple reason that, at least in the early days, we had a virus
we didn't know working against us. It's like pouring water into
a bucket that has a hole in the bottom. Until you can plug up
the hole by getting rid of the virus, no biological response
modifiers will work.''

Mansell believes that the spectrum of malignant diseases that
may afflict AIDS patients is not even known yet-which, in
the negative,positive way these things operate, draws oncologists
to AIDS research and treatment. "It's clear," he said, "that
one of the etiologic factors in cancer is dysfunction of the
immune system. What we've learned about manipulating the
immune system, even though unsuccessfully in AIDS initially,
is a tremendous spinoff. Once we get an effective antiviral drug
and can get rid of the hole in the bottom of the bucket, what
we've learned about the use of biological response modifiers in
the course of treating AIDS patients will enable us to fill up
the bucket very quickly ."

Counseling Patients with AIDS and ARC
Begins with Unconditional Acceptance
"I think a very important thing is
that we have to accept each person,
and it cannot be conditional. That's
what I tell people now."
That's how Sue Cooper, M.S.W.,
explains her job as d · c or o
e
Department of Social Services of the
newly opened Institute for
Immunological Disorders.
"I really had to look at what my
motivation was and if I thought I
could do it. I had to look at my own Sue Cooper
value system and make sure that I
was not more of a hindrance than a help. Oftentimes I think
the patients read us as quickly as we read them," she said.
Cooper came to her job from UT MDAH, where she had
worked with patients with AIDS (acquired immune deficiency
syndrome) since UT MDAH began treating these patients about
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four and a half years ago.
"I see our patients as human beings who are sick and need
care. I don't have to be into moral judgments. My place is to
do what I do well, and I hope that is to be a good social worker,"
said Cooper, a former housewife who returned to school at
m1 1 e to earn a master s egree. e interne at MDAH an
changed from working there as a student one Friday to working
as a full,time paid employee the next Monday.
Problems of starting from scratch-being part of a new
hospital, acting as the only social worker, and facing the task
of hiring other support staff members seem conquerable to
Cooper, and she has high expectations of the people she hires.
Asked about horror stories concerning the disease, Cooper
answered the question in her own way. ''There are horror stories
about AIDS," she said, "because AIDS patients have so few
resources. One horror story, for example, might be: 'John had
no place to go, and he was so sick that he just curled up and
died.' That's a horror story, not so much about the disease, but
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The first essential step, he said, is to be able to get rid of the
virus. Equally important is education for prevention, because
the development of a vaccine will take several years, and even
then the vaccine will be useful only for people not infected by
the virus.

Not to Repeat African Experience
We know now, Mansell said, that AIDS ha_s been in Africa
for 15 or 20 years, started by a simian virus that transferred itself
to humans. '' And when we look at what is happening in Central
Africa, we may be looking through a window into our future.
In Kinshasa, Zaire, for example, which has a population about
the size of Houston's, the AIDS incidence is 100 cases per
100,000 population. Ten percent of children are infected by the
virus and equal numbers of men and women.
"AIDS is a threat to everybody. As Surgeon General Everett
Koop urged in his report, we ought to be teaching school
children how to avoid it. We have the knowledge, if people
would accept it, to reduce the incidence of the disease
significantly by teaching people to avoid multiple promiscuous
sexual partners and not to inject drugs with dirty needles.
"A few years ago many people regarded AIDS as a just
visitation on people who had earned it, but it's obvious now
that this is a sexually transmitted disease that is as much a
menace to society in general as it is to any particular risk group.
Although the great majority of AIDS patients will continue to

be in certain high,risk groups, of which drug abusers are
becoming one of the most significant, no group in society is
innately not at risk," Mansell said.
He and his associates are determined "to get really involved
at the grass roots of education," he said. "We hope that this
institute with its focus of interest and, I hope, expertise will
enable us to speak with a strong voice."
This hope was expressed also by 1
· --------------,
Adan A. Rios, M.D., director of the
institute's Department of Medical
Oncology and an assistant professor
at UT MDAH. "Right now," Rios
said, ''we are looking at this place
as a potential source for AIDS
education, prevention, therapy, and
research, and we hope to develop the
institution in a way that will be
attractive for all who want to learn
about this disease and to participate Adan A. Rios
in our work.''
"We have a feeling here," Mansell added, "of being pioneers
in a sense, of trying to address a problem as well as it can be
done.''

Physicians who desire additional information may write Peter W.
A. Mansell, M.D., Institute for Immunologi,cal Disorders, 7407
North Freeway, Houston, Texas 77076.

but they are afraid to make decisions. They don't know their
future-they may get AIDS or they may live another 50 years,"
she said.
Having AIDS forces a completely different view on patients.
"People who have AIDS face the reality that they probably will
not to be able to work much longer," Cooper said, "and they
have to start making very 'now' sorts of decisions: Where am

Institute for Immunological Disorders

about loss of support systems."
The institute's social support groups for patients, family
members, and life partners started to meet a month after the
hospital opened. Cooper pointed out that patients with AIDS
and ARC (AIDS,related complex), though treated in the same
environment, have different needs.

Lives Long or Short
"ARC patients have been labeled 'the worried well' because
they are so afraid they are going to get AIDS that it sometimes
immobilizes them. They are trying to carry on a normal life,
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I going to live? Where do I want to be treated? How far do I
want to go with treatment? Do I want to go home and not do
anything? And most important, What's important to me now?"
Cooper said that counseling those with AIDS is not dissimilar
from counseling others with chronic diseases, except that these
patients' chances of surviving are much lower, and they have
probably seen many of their friends die or become sick from
the same disease.
''You take the normal person off the street and ask him what
he knows about cancer. Do you think he could tell you very
much? You ask someone if he knows about arthritis, or multiple
sclerosis, or even Alzheimer's disease. But you ask a man who
is gay what he knows about AIDS, and you get a lot of
information,'' Cooper said.
"They are very aware of what it means to have AIDS," she
said.
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Texans Plan Network of Cancer Resources
The Texas Cancer Plan, a design to advance control of cancer
in Texas through four major initiatives, was formally presented
to Texas House Speaker Gib Lewis in September by a legislative
task force, whose members included UT System Cancer Center
President Charles A. LeMaistre, M.D., and Joseph T . Painter,
M.D., a UT MDAH vice president.
Ordered developed and implemented by the 69th Texas
Legislature, the Texas Cancer Plan is the product of the 52,
member Legislative Task Force on Cancer appointed in 1984
by Lewis and chaired by James D. Dannenbaum, a UT MDAH
volunteer and seven,year member of the Board of Visitors. The
task force was charged with evaluating the burden of cancer
on Texans and designing methods of reducing it.

Wide-Ranging Goals
The Texas Cancer Plan's four major goals are (1) lowering
the risk of developing cancer; (2) detecting, diagnosing, and
treating cancer earlier when cure is more likely; (3) improving
the accessibility, availability, and quality of cancer resources,
services, and programs; and (4) advancing control of cancer
through development and application of new prevention,
detection, diagnostic, and therapeutic methods. On the basis
of the task force's initial report, which was an interim plan
addressing immediate priorities, the Texas Legislature created
the 16,member Texas Cancer Council (TCC), and it
appropriated $7 million for the 1986,1987 biennium to put the
interim plan into operation. Now it is the Texas Cancer
Council's job to implement and monitor the development of
a coordinated, comprehensive network of cancer resources in
this state. Painter, who is UT MDAH vice president for
physician referral development and extramural programs,
directed the task force staff and now serves on the TCC
executive committee.

First State Cancer Plan
The Texas Cancer Plan is the first state,level plan of its kind
in the country. '' A program focusing on prevention, early
detection, and networking became feasible based on the success
against cancer nationwide," said Owen F. McCrory, director
of extramural programs at UT MDAH. ''The state of Texas has
a long history of being interested in cancer, as evidenced by
its creation and support of M. D. Anderson Hospital. Our
knowledge of how to prevent cancer, and specific tools and
techniques for detection, are relatively recent developments."
The TCC has already put some of the interim objectives into
practice. For example, cancer screening programs in local health
departments and nurses' training in cancer prevention and
detection techniques were expanded. In addition, the Office
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of Smoking and Health in the Texas Department of Health
(TOH) was created to promote prevention and cessation of
tobacco use. As a result of the comprehensive school health
education program developed by the Texas Education Agency
and supported by the TCC, 82% of Texas schoolchildren are
being taught about cancer and other health issues. This program
will be developed further during the next fiscal year as teacher
training in health education is extended.
Special projects began operating. In the Rio Grande Valley
cancer screening in public health clinics is now coupled with
diagnostic follow,up by local physicians or transportation to the
nearest cancer center when necessary, and a valleywide cancer
prevention program has been developed. In East Texas, the
TCC supported a study on nutrition and cancer among black
people. In addition, the TCC provided funds to help the state
health department expand collection and analysis of cancer
incidence data and to create the Texas Cancer Data Center
for collecting and correlating information on cancer resources,
services, and programs.
Through the hospital,based Statewide Cancer Registry
Program operated by the TOH, comprehensive data are being
collected from seven of the 12 public health regions, and
eventually information will be obtained from the others to create
a statewide cancer incidence profile.

Money to Keep Program Going
The TCC has requested $8.9 million from the legislature to
operate the Texas Cancer Plan during 1988,1989. About 75%
is earmarked for continued organization and operation of cancer
prevention programs; 10% is allocated to maintaining the Rio
Grande Valley programs; about 7% will be used to establish a
jointly funded communication network among community
cancer centers; and 6% is assigned to continuing the cancer
resources data system and evaluating TCC initiatives. The
remaining funds are for administration.
The objectives of the Texas Cancer Plan are twofold: first ,
to thoroughly educate every Texan about cancer, and second,
to make cancer care easily accessible. The hope is that new
cancer cases and deaths from this disease will decrease
significantly; that the pain, suffering, and disability of those
afflicted with cancer will be diminished; and that the substantial
personal and economic costs of caring for those who have cancer
will be reduced.
Copies of the Texas Cancer Plan are available from the Office
of the Vice President for Physician Referral Development and
Extramural Affairs, The University of Texas M. D. Anderson
Hospital and Tumor Institute at Houston, 1515 Holcombe
Boulevard, Houston, Texas 77030.
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What Types of Conferences Do Texas Physicians Want?
To help the Office of Conference Services at UT M. D.
Anderson Hospital meet the needs of Texas physicians for
oncology education, OncoLog readers are asked to fill out the
questionnaire below.

9. Is the cost of a conference a factor?

D Yes

□ No

10. What do you consider an appropriate fee for:
Hotel _______

Please check each category that applies to you.
□ Clinic
D Private

D Hospital,based
D Academic

D Research
D Other _ _ _ _ __

Size of practice _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
□ Rural

Location of practice

Area of specialty _ _ _ __ _

□ City

Subspeciality _ _ _ __

How many years in practice?
□

□

6,10

Registration _ __ _ __ _

11. Do you regularly receive information about
M. D. Anderson conferences?
D Yes

□ No

12. If yes, how?
D Direct mail
□ OncoLog
D Journal announcements
D Advertisements D Other _ _ _ _ _ _ _ _ __
13. If not, would you like to receive information?

□

11,15

□ 20+

16,20

1. How many major medical conferences a year do you
normally attend?
At M. D. Anderson____

□ Yes

□ No

Your address: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Others _ _ __

2. Why do you attend?
D Education/CME
D Resort

D Content
D Location

14. What method of conference presentation do you prefer?

3. Does your spouse attend conferences with you?

D Yes

D No

D Sometimes

D Always

4. Do offerings for spouses influence your attendance?
D Yes

□ No

□

Sometimes

D Always

5. Please list by priority three topics you would like to see
presented.
l. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

2. - - - -- - - - - - - - - - - - - - - - -

3. _ ___________________
6. What other medically related topics would you be
interested in learning more about?

D Small group
D Large group
D Lectures plus supplementary materials
D Round,table discussion
D Other
General comments _ _ _ _ _ _ _ _ _ _ _ _ __

Thank you for answering these questions. We promise to use
the information for developing programs that will meet the

needs of Texas physicians and others.
Please return to: Office of Conference Services
M. D. Anderson Hospital-HMB Box 131
1515 Holcombe Boulevard
Houston, Texas 77030

7. When do you prefer to attend conferences?
D Weekdays

D Weekends

D Combination

8. What time of year do you prefer for conferences?
D Spring

Vol. 32, No. 1

□ Summer

D Fall

D Winter
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1985 Research Report: Long Story, Tersely Told
To assemble a cadre of talented scientists working in new
spaces, to gain a clearer understanding of cancer causes and
design new therapies-near goals almost met, according to
Frederick F. Becker, M.D., vice president for research, in his
foreword to the UT System Cancer Centers Annual Research

Report 1985.
Enumerating "the recruitment of an outstanding scientific
staff, the development of new technology, the construction of
superior facilities, and the instigation of collaborative studies
between basic and clinical research groups," Becker expressed
the belief that the results of "this enormous expansion and
improvement of our research capabilities" will be rapidly
evident.
The 230,page illustrated research report contains brief
descriptions of the work of each division, department, and
section. William J. Lennarz, Ph.D., chairman of the Department
of Biochemi try and Molecular Biology, begins it by describing
work related to the biosynthesis and function of cell,surface
glycoproteins, which are believed to play a role in cell
recognition events in both normal and abnormal growth and
differentiation.
T award the end of the alphabetically arranged department
reports is one by Garth L. Nicolson, Ph.D., chairman of the
Department of Tumor Biology, on work directed to detecting
and eliminating tumor cells: "understanding basic mechanisms
of neoplastic transformation, aberrant cell growth, genetic
instability, and other tumor cell properties; determining how
host antitumor mechanisms recognize and kill or inhibit the
growth of tumor cells; and determining how differences in tumor
cell properties can be used to identify and remove malignant
cells from normal cell populations."
Between these two sections are necessarily terse summaries
of the institution's range of basic and clinical work-from
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biomathematics, through cell biology, diagnostic imaging,
genetics, immunology, laboratory medicine, medicine,
pathology, pediatrics, radiotherapy, and surgery, to veterinary
medicine and resources.
The 1985 research report is a mirror of one part of the
institution's work, a place to start if one wants a quick look
at what goes on here in cancer research.
The report will have national and international library
distribution. A limited number of copies are available free from
the Department of Scientific Publications, The University of
Texas M. D. Anderson Hospital and Tumor Institute at
Houston, 1515 Holcombe Boulevard, Houston, Texas 77030
-- (713) 792,3305.

Minority Communities
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♦

continued f,-om page 3

and persons at the national level involved in health care
planning. That is the overall aim of the symposium to be held
in Houston.
Cancer is an "equal opportunity disease" and a major public
health problem. The majority of participants in this symposium
are nationally known, but the true success of the conference will
be its ability to attract primary care physicians and oncologists
of all racial and ethnic backgrounds, as well as the general
public, so that they may become acquainted with the realities
of the cancer problem.

Physicians who desire additional information may write Lovell A.
Jones, Ph.D. , Department of Gynecology, Box 67, The University
of Texas M. D. Anderson Hospital and Tumor Institute at Houston,
1515 Holcombe Boulevard, Houston, Texas 77030.

